Search

Search Constraints

You searched for: Author/Creator Grand'Maison, Francois

Search Results

1. 004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis. (23rd August 2021)

2. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. (14th June 2022)

3. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. (October 2018)

4. Comparative effectiveness in multiple sclerosis: A methodological comparison. (March 2023)

5. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis. (August 2015)

6. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Issue 4 (13th January 2019)

7. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

8. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

9. Contribution of different relapse phenotypes to disability in multiple sclerosis. (February 2017)

10. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]. (January 2022)